Annexin A2 Regulates the Levels of Plasmin, S100A10 and Fascin in L5178Y Cells

REFERENCES

• Moss S. E., Morgan R. O. The annexins. Genome Biol 2004; 5: 219
   PubMed Web of Science ®Google Scholar
• Gerke V., Moss S. E. Annexins: From structure to function. Physiol Rev 2001; 82: 331–371
   Web of Science ®Google Scholar
• Chetcuti A., Margan S. H., Russell P., Mann S., Millar D. S., Clark S. J., et al. Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res 2001; 61: 6331–6334
   PubMed Web of Science ®Google Scholar
• Cesarman-Maus G., Hajjar K. A. Molecular mechanisms of fibrinolysis. Br J Haematol 2005; 129: 307–321
   PubMed Web of Science ®Google Scholar
• Tuszynski G. P., Sharma M. R., Rothman V. L., Sharma M. C. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells. Microvascular Res 2002; 64: 448–462
   PubMed Web of Science ®Google Scholar
• Kwon M., Caplan J. F., Filipenko N. R., Choi K. S., Fitzpatrick S. L., Zhang L., et al. Identification of annexin II heterotetramer as a plasmin reductase. J Biol Chem 2002; 277: 10903–10911
   PubMed Web of Science ®Google Scholar
• Waisman D. M. Annexin A2 may not play a role as a plasminogen receptor. Br J Haematol 2005; 131: 553–554
   PubMed Web of Science ®Google Scholar
• Kwon M., MacLeod T. J., Zhang Y., Waisman D. M. S100A10, annexin A2, and annexin A2 heterotetramer as candidate plasminogen receptors. Front Biosci 2005; 10: 300–325
   PubMed Web of Science ®Google Scholar
• Semov A., Moreno M. J., Onichtchenko A., Abulrob A., Ball M., Ekiel I., et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005; 280: 20833–20841
   Google Scholar
• Garrett S. C., Varney K. M., Weber D. J., Bresnick A. R. S100A4, a mediator of metastasis. J Biol Chem 2006; 281: 677–680
   PubMed Web of Science ®Google Scholar
• Sharma M. R., Koltowski L., Ownbey R. T., Tuszynski G. P., Sharma M. C. Angiogenesis-associated protein annexin II in breast cancer: Selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 2006; 81: 146–156
   PubMed Web of Science ®Google Scholar
• Sharma M. R., Rothman V., Tuszynski G. P., Sharma M. C. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action. Exp Mol Pathol 2006; 81: 136–145
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Shimada Y., Kawamura J., Yamasaki S., Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncol 2004; 67: 262–270
   Google Scholar
• Pelosi G., Pastorino U., Pasini F., Maissoneuve P., Fraggetta F., Iannucci A., et al. Independent prognostic value of fascin immunoreactivity in stage I non-small cell lung cancer. Br J Cancer 2003; 88: 537–547
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Ito T., Inoue H., Okumura T., Tanaka E., Tsunoda S., et al. Prognostic significance of fascin overexpression in human esophageal squamouscell carcinoma. Clin Cancer Res 2005; 11: 2597–2605
   PubMed Web of Science ®Google Scholar
• Hou Y., Hirata A., Hirata F. Construction of mouse annexin II gene knockout recombinant and generation of mouse annexin II-/-cell line. Chin J Cell Biol 2006; 28: 721–725
   Google Scholar
• Livak K. J., Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ CT) method. Methods 2001; 25: 402–408
   PubMed Web of Science ®Google Scholar
• Markoff A., Gerke V. Expression and functions of annexins in the kidney. Am J Physiol Renal Physiol 2005; 289: F949–956
   PubMed Web of Science ®Google Scholar
• Liu J. W., Shen J. J., Tanzillo-Swarts A., Bhatia B., Maldonado C. M., Person M. D., et al. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 2003; 22: 1475–1485
   PubMed Web of Science ®Google Scholar
• Domoto T., Miyama Y., Suzuki H., Teratani T., Arai K., Sugiyama T., et al. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci 2007; 98: 77–82
   PubMed Web of Science ®Google Scholar
• Zhang L., Fogg D. K., Waisman D. M. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem 2004; 279: 2053–2062
   PubMed Web of Science ®Google Scholar
• Diaz V. M., Hurtado M., Thomson T. M., Reventós J., Paciucci R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 2004; 53: 993–1000
   PubMed Web of Science ®Google Scholar
• Brownstein C., Falcone D. J., Jacovina A., Hajjar K. A. A mediator of cell surface-specific plasmin generation. Ann NY Acad Sci 2001; 947: 143–156
   PubMed Web of Science ®Google Scholar
• Kim J., Hajjar K. A. Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 2002; 7: d341–348
   PubMed Web of Science ®Google Scholar
• Hajjar K. A., Krishnan S. Annexin II: a mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med 1999; 9: 128–138
   PubMed Web of Science ®Google Scholar
• Fitzpatrick S. L., Kassam G., Choi K. S., Kang H. M., Fogg D. K., Waisman D. M. Regulation of plasmin activity by annexin II tetramer. Biochemistry 2000; 39: 1021–1028
   PubMed Web of Science ®Google Scholar
• Kang H. M., Choi K. S., Kassam G., Fitzpatrick S. L., Kwon M., Waisman D. M. Role of annexin II tetramer in plasminogen activation. Trends Cardiovasc Med 1999; 9: 92–102
   PubMed Web of Science ®Google Scholar
• Kassam G., Choi K. S., Ghuman J., Kang H. M., Fitzpatrick S. L., Zackson T., et al. The role of annexin II tetramer in the activation of plasminogen. J Biol Chem 1998; 273: 4790–4799
   PubMed Web of Science ®Google Scholar
• Vignjevic D., Schoumacher M., Gavert N., Janssen K. P., Jih G., Laé M., et al. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 2007; 67: 6844–6853
   PubMed Web of Science ®Google Scholar
• Adams J. C. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004; 16: 590–596
   PubMed Web of Science ®Google Scholar
• Chen S. F., Yang S. F., Li J. W., Nieh P. C., Lin S. Y., Fu E., et al. Expression of fascin in oral and oropharyngeal squamous cell carcinomas has prognostic significance—a tissue microarray study of 129 cases. Histopathol 2007; 51: 173–183
   PubMed Web of Science ®Google Scholar
• Lee T. K., Poon R. T., Man K., Guan X. Y., Ma S., Liu X. B., et al. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett. Epub. 2007
   Google Scholar
• Tsai W. C., Chao Y. C., Sheu L. F., Chang J. L., Nieh S., Jin J. S. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers 2007; 23: 153–160
   PubMed Web of Science ®Google Scholar
• Okada K., Shimura T., Asakawa K., Hashimoto S., Mochida Y., Suehiro T., et al. Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer. Hepatogastroenterology 2007; 54: 17–21
   PubMed Web of Science ®Google Scholar